Biomea Fusion Inc

General ticker "BMEA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $216.3M

Biomea Fusion Inc does not follow the US Stock Market performance with the rate: -24.0%.

Estimated limits based on current volatility of 7.1%: low 3.83$, high 4.42$

Factors to consider:

  • Current price 31.6% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.89$, 15.25$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.09$, 10.96$]

Financial Metrics affecting the BMEA estimates:

  • Negative: Non-GAAP EPS, $ of -3.46 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -16.20 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term BMEA quotes

Long-term BMEA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $41.67MM $83.63MM $126.14MM
Operating Income $-41.67MM $-83.63MM $-126.14MM
Non-Operating Income $0.10MM $1.81MM $8.88MM
R&D Expense $28.00MM $62.71MM $102.55MM
Income(Loss) $-41.57MM $-81.83MM $-117.25MM
Profit(Loss) $-41.57MM $-81.83MM $-117.25MM
Stockholders Equity $178.78MM $108.54MM $169.24MM
Assets $185.71MM $129.31MM $199.93MM
Operating Cash Flow $-35.44MM $-62.42MM $-96.59MM
Capital expenditure $3.17MM $1.03MM $3.37MM
Investing Cash Flow $-33.35MM $27.34MM $-2.22MM
Financing Cash Flow $153.19MM $1.24MM $163.80MM
Earnings Per Share* $-1.73 $-2.73 $-3.44

* EPS are Split Adjusted, recent splits may be reflected with a delay.